Zhiguo Li et al. 2022. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis. Turkish Journal of Gastroenterology. 33, 2 (Feb. 2022), 136–144.